标题
Targeted therapy in rare cancers—adopting the orphans
作者
关键词
-
出版物
Nature Reviews Clinical Oncology
Volume 9, Issue 11, Pages 631-642
出版商
Springer Nature
发表日期
2012-09-11
DOI
10.1038/nrclinonc.2012.160
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- How I treat CML blast crisis
- (2012) R. Hehlmann BLOOD
- Functional features of RUNX1 mutants in acute transformation of chronic myeloid leukemia and their contribution to inducing murine full-blown leukemia
- (2012) L.-J. Zhao et al. BLOOD
- Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia
- (2012) R. Beekman et al. BLOOD
- Myeloma as a model for the process of metastasis: implications for therapy
- (2012) I. M. Ghobrial BLOOD
- Estimations of the increasing prevalence and plateau prevalence of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy
- (2012) Xuelin Huang et al. CANCER
- Crizotinib for ALK-Rearranged Non-Small Cell Lung Cancer: A New Targeted Therapy for a New Target
- (2012) L. Gandhi et al. CLINICAL CANCER RESEARCH
- Quantitative Cell-Free DNA, KRAS, and BRAF Mutations in Plasma from Patients with Metastatic Colorectal Cancer during Treatment with Cetuximab and Irinotecan
- (2012) K.-L. G. Spindler et al. CLINICAL CANCER RESEARCH
- KRAS and BRAF Mutations Predict Primary Resistance to Imatinib in Gastrointestinal Stromal Tumors
- (2012) C. Miranda et al. CLINICAL CANCER RESEARCH
- One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor
- (2012) Heikki Joensuu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II Study
- (2012) Barbara Pro et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Biomarker Evaluation From the AVAGAST Randomized Phase III Trial
- (2012) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
- (2012) Anas Younes et al. JOURNAL OF CLINICAL ONCOLOGY
- The role of BRAF V600 mutation in melanoma
- (2012) Paolo A Ascierto et al. Journal of Translational Medicine
- Analysis of Mutations in the BCR-ABL1 Kinase Domain, Using Direct Sequencing
- (2012) Filip Razga et al. Molecular Diagnosis & Therapy
- Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
- (2012) Anirudh Prahallad et al. NATURE
- Brentuximab vedotin
- (2012) Anas Younes et al. NATURE REVIEWS DRUG DISCOVERY
- BRAF Inhibition in Refractory Hairy-Cell Leukemia
- (2012) Sascha Dietrich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structural and Spectroscopic Analysis of the Kinase Inhibitor Bosutinib and an Isomer of Bosutinib Binding to the Abl Tyrosine Kinase Domain
- (2012) Nicholas M. Levinson et al. PLoS One
- Myelodysplastic syndromes: 2011 update on diagnosis, risk-stratification, and management
- (2011) Guillermo Garcia-Manero AMERICAN JOURNAL OF HEMATOLOGY
- Phase II Trial of Neoadjuvant/adjuvant Imatinib Mesylate for Advanced Primary and Metastatic/recurrent Operable Gastrointestinal Stromal Tumors: Long-term Follow-up Results of Radiation Therapy Oncology Group 0132
- (2011) Dian Wang et al. ANNALS OF SURGICAL ONCOLOGY
- A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q
- (2011) P. Fenaux et al. BLOOD
- Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis
- (2011) Philippe A. Cassier et al. CANCER
- Mosaic Amplification of Multiple Receptor Tyrosine Kinase Genes in Glioblastoma
- (2011) Matija Snuderl et al. CANCER CELL
- Durable remission after treatment with very low doses of imatinib for FIP1L1-PDGFRα-positive chronic eosinophilic leukaemia
- (2011) Grzegorz Helbig et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Advances in therapies for acute promyelocytic leukemia
- (2011) Tomohiko Kamimura et al. CANCER SCIENCE
- Trastuzumab Emtansine (T-DM1): A Novel Agent for Targeting HER2+ Breast Cancer
- (2011) Howard A. Burris et al. Clinical Breast Cancer
- Vemurafenib and BRAF Inhibition: A New Class of Treatment for Metastatic Melanoma
- (2011) J. J. Luke et al. CLINICAL CANCER RESEARCH
- Phase I Trial of Cixutumumab Combined with Temsirolimus in Patients with Advanced Cancer
- (2011) Aung Naing et al. CLINICAL CANCER RESEARCH
- Outcome of Treatment of Chronic Myeloid Leukemia With Second-Generation Tyrosine Kinase Inhibitors After Imatinib Failure
- (2011) A. Megan Cornelison et al. Clinical Lymphoma Myeloma & Leukemia
- Effectiveness of adaptive designs for phase II cancer trials
- (2011) Martha Fors López et al. Contemporary Clinical Trials
- CD30-targeted antibody therapy
- (2011) Anas Younes CURRENT OPINION IN ONCOLOGY
- Molecular Analysis of Thyroid Tumors
- (2011) Feriyl Bhaijee et al. ENDOCRINE PATHOLOGY
- Rare cancers are not so rare: The rare cancer burden in Europe
- (2011) Gemma Gatta et al. EUROPEAN JOURNAL OF CANCER
- Anaplastic lymphoma kinase as a new target for the treatment of non-small-cell lung cancer
- (2011) Marcello Tiseo et al. Expert Review of Anticancer Therapy
- Brentuximab vedotin for the treatment of CD30+lymphomas
- (2011) Kelley V Foyil et al. Immunotherapy
- Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients With Medullary Thyroid Cancer
- (2011) Razelle Kurzrock et al. JOURNAL OF CLINICAL ONCOLOGY
- Response of Lymphangioleiomyomatosis to a Mammalian Target of Rapamycin Inhibitor (Temsirolimus) –Based Treatment
- (2011) Sarina A. Piha-Paul et al. JOURNAL OF CLINICAL ONCOLOGY
- Responses to Liposomal Doxorubicin, Bevacizumab, and Temsirolimus in Metaplastic Carcinoma of the Breast: Biologic Rationale and Implications for Stem-Cell Research in Breast Cancer
- (2011) Stacy Moulder et al. JOURNAL OF CLINICAL ONCOLOGY
- Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial
- (2011) Samuel A. Wells et al. JOURNAL OF CLINICAL ONCOLOGY
- Dermatofibrosarcoma protuberans: A clinicopathological, immunohistochemical, genetic ( COL1A1-PDGFB ), and therapeutic study of low-grade versus high-grade (fibrosarcomatous) tumors
- (2011) Beatriz Llombart et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Vemurafenib
- (2011) Keith. T Flaherty et al. NATURE REVIEWS DRUG DISCOVERY
- Crizotinib in Anaplastic Large-Cell Lymphoma
- (2011) Carlo Gambacorti-Passerini et al. NEW ENGLAND JOURNAL OF MEDICINE
- BRAFMutations in Hairy-Cell Leukemia
- (2011) Enrico Tiacci et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Mosaic Activating Mutation inAKT1Associated with the Proteus Syndrome
- (2011) Marjorie J. Lindhurst et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Castleman's Disease: From Basic Mechanisms to Molecular Therapeutics
- (2011) H. E. El-Osta et al. ONCOLOGIST
- Targeted Morphoproteomic Profiling of Ewing's Sarcoma Treated with Insulin-Like Growth Factor 1 Receptor (IGF1R) Inhibitors: Response/Resistance Signatures
- (2011) Vivek Subbiah et al. PLoS One
- R1507, an Anti-Insulin-Like Growth Factor-1 Receptor (IGF-1R) Antibody, and EWS/FLI-1 siRNA in Ewing's Sarcoma: Convergence at the IGF/IGFR/Akt Axis
- (2011) Helen J. Huang et al. PLoS One
- Clinical utility of vandetanib in the treatment of patients with advanced medullary thyroid cancer
- (2011) Hari Deshpande et al. OncoTargets and Therapy
- Diabetes and Cancer: Is Diabetes Causally Related to Cancer?
- (2011) Sunghwan Suh et al. Diabetes & Metabolism Journal
- Deletions of Immunoglobulin heavy chain and T cell receptor gene regions are uniquely associated with lymphoid blast transformation of chronic myeloid leukemia
- (2010) Elisabeth P Nacheva et al. BMC GENOMICS
- A decade of tyrosine kinase inhibitor therapy: Historical and current perspectives on targeted therapy for GIST
- (2010) Jean-Yves Blay CANCER TREATMENT REVIEWS
- A Phase I Study of Weekly R1507, A Human Monoclonal Antibody Insulin-like Growth Factor-I Receptor Antagonist, in Patients with Advanced Solid Tumors
- (2010) R. Kurzrock et al. CLINICAL CANCER RESEARCH
- Pleiotropic mechanisms of action of lenalidomide efficacy in del(5q) myelodysplastic syndromes
- (2010) Carla Heise et al. Expert Review of Anticancer Therapy
- Dermatofibrosarcoma protuberans-derived fibrosarcoma: Clinical history, biological profile and sensitivity to imatinib
- (2010) Silvia Stacchiotti et al. INTERNATIONAL JOURNAL OF CANCER
- Equipoise Lost: Ethics, Costs, and the Regulation of Cancer Clinical Research
- (2010) David J. Stewart et al. JOURNAL OF CLINICAL ONCOLOGY
- Siltuximab, a Novel Anti–Interleukin-6 Monoclonal Antibody, for Castleman's Disease
- (2010) Frits van Rhee et al. JOURNAL OF CLINICAL ONCOLOGY
- Successful Treatment of Castleman's Disease with Interleukin-1 Receptor Antagonist (Anakinra)
- (2010) H. El-Osta et al. MOLECULAR CANCER THERAPEUTICS
- EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors
- (2010) Young Lim Choi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lenalidomide in Myelodysplastic Syndromes: An Erythropoiesis-Stimulating Agent or More?
- (2010) Rami S. Komrokji et al. Current Hematologic Malignancy Reports
- Anti-CD30 Antibodies for Hodgkin Lymphoma
- (2010) Kelley V. Foyil et al. Current Hematologic Malignancy Reports
- Castleman Disease
- (2009) Danielle M. P. Cronin et al. ADVANCES IN ANATOMIC PATHOLOGY
- BRAFMutation Status in Gastrointestinal Stromal Tumors
- (2009) Isabelle Hostein et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- The heterogeneous prognosis of patients with myelodysplastic syndrome and chromosome 5 abnormalities
- (2009) Hagop Kantarjian et al. CANCER
- AP24163 Inhibits the Gatekeeper Mutant of BCR-ABL and SuppressesIn vitroResistance
- (2009) Mohammad Azam et al. Chemical Biology & Drug Design
- Phase I, Pharmacokinetic, and Pharmacodynamic Study of AMG 479, a Fully Human Monoclonal Antibody to Insulin-Like Growth Factor Receptor 1
- (2009) Anthony W. Tolcher et al. JOURNAL OF CLINICAL ONCOLOGY
- p53 nuclear accumulation is associated with extramedullary progression of multiple myeloma
- (2009) Neil Sheth et al. LEUKEMIA RESEARCH
- Melanoma troops massed
- (2009) Paul H. Huang et al. NATURE
- Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia
- (2009) J. Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Maladie de Castleman à expression thoracique
- (2009) T. Dégot et al. Revue de Pneumologie Clinique
- Cluster of Hodgkin’s lymphoma in residents near a non-operational petroleum refinery
- (2009) J Dahlgren et al. TOXICOLOGY AND INDUSTRIAL HEALTH
- Heterogeneity in cancer guidelines: should we eradicate or tolerate?
- (2008) G. Pentheroudakis et al. ANNALS OF ONCOLOGY
- Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease
- (2008) N. Nishimoto et al. BLOOD
- Acute promyelocytic leukemia: from highly fatal to highly curable
- (2008) Z.-Y. Wang et al. BLOOD
- Preceding orbital granulocytic sarcoma in an adult patient with acute myelogenous leukemia with t(8;21): a case study and review of the literature
- (2008) Sang-Guk Lee et al. CANCER GENETICS AND CYTOGENETICS
- Chemoprevention and Treatment of Experimental Cowden's Disease by mTOR Inhibition with Rapamycin
- (2008) C. H. Squarize et al. CANCER RESEARCH
- Primary extramedullary plasmacytoma: similarities with and differences from multiple myeloma revealed by interphase cytogenetics
- (2008) K. Bink et al. HAEMATOLOGICA
- Anaplastic Large-Cell Lymphoma in Women With Breast Implants
- (2008) Daphne de Jong JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical research for rare disease: Opportunities, challenges, and solutions
- (2008) Robert C. Griggs et al. MOLECULAR GENETICS AND METABOLISM
- Prevalence of zebras in general practice: Data from the Continuous Morbidity Registration Nijmegen
- (2008) Floris A. van de Laar et al. European Journal of General Practice
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation